Showing results (301-310 of 312) with videos related to
Sort By:
Pageof 32
Biorxiv : the Preprint Server for Biology|December 10, 2020
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine and Pyronaridine: In vitro Activity Against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan James Fritch, Thomas R Lane, et al.ACS Omega|March 29, 2021
Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential MechanismsAna C Puhl, Ethan J Fritch, Thomas R Lane, et al.Neurology|November 11, 2018
Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitisKevin Messacar, Stefan Sillau, Sarah E Hopkins, et al.Cell|October 27, 2015
Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activityMichael D Swanson, Daniel M Boudreaux, Loïc Salmon, et al.Biorxiv : the Preprint Server for Biology|November 3, 2020
A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cellsDrake M Mellott, Chien-Te Tseng, Aleksandra Drelich, et al.Nature Communications|April 8, 2022
Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19Hengrui Liu, Sho Iketani, Arie Zask, et al.Nature Communications|March 28, 2023
Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2Brian C Sanders, Suman Pokhrel, Audrey D Labbe, et al.Nature Medicine|August 18, 2022
Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2Rachel J Hagey, Menashe Elazar, Edward A Pham, et al.ACS Chemical Biology|March 31, 2021
A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey CellsDrake M Mellott, Chien-Te Tseng, Aleksandra Drelich, et al.Science (New York, N.Y.)|November 2, 2021
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19Dafydd R Owen, Charlotte M N Allerton, Annaliesa S Anderson, et al.Pageof 32